Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study

BACKGROUND: Treatment of pulmonary sarcoidosis is recommended in case of significant symptoms, impaired or deteriorating lung function. Evidence-based treatment recommendations are limited and largely based on expert opinion. Prednisone is currently the first-choice therapy and leads to short-term i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Pulm Med
Asıl Yazarlar: Kahlmann, Vivienne, Janssen Bonás, Montse, Moor, Catharina C., van Moorsel, Coline H. M., Kool, Mirjam, Kraaijvanger, Raisa, Grutters, Jan C., Overgaauw, Mayka, Veltkamp, Marcel, Wijsenbeek, Marlies S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Study Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7574228/
https://ncbi.nlm.nih.gov/pubmed/33076885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-020-01290-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller